GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16

Analyse Crystal structure of SARS-cov-2 B.1.351 variant receptor binding domain in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7S5Q
Type
protein
Length
1,068 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; CS44 heavy chain; CS44 light chain; COVA1-16 heavy chain; COVA1-16…
UniProt
P0DTC2
Ligands
NAG, SO4
Pockets
16 · best druggability 0.68

Structure

x-ray diffraction · 5 distinct chains · 9% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein19818% helix, 30% strandP0DTC2
BCS44 heavy chainprotein2193% helix, 53% strand—
CCS44 light chainprotein2147% helix, 51% strand—
HCOVA1-16 heavy chainprotein2259% helix, 50% strand—
LCOVA1-16 light chainprotein2126% helix, 52% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • SO4 · Sulfate ion · ion · 11 copies · chains A, B, H, L
  • EDO · 1,2-ethanediol · additive · 5 copies · chains A, H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

16 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18430.680.7572empty
26120.640.7559empty
36060.620.7453SO4
42240.550.7834EDO
54110.550.7343empty

Interfaces

8 interfaces between chains.

  • B–C · 1727 Ų buried · 14 hydrogen bonds · protein-protein
  • H–L · 1689 Ų buried · 18 hydrogen bonds · protein-protein
  • A–H · 738 Ų buried · 14 hydrogen bonds · protein-protein
  • A–B · 526 Ų buried · 8 hydrogen bonds · protein-protein
  • B–L · 336 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 13 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7S5Q · Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.